A tailored approach to involve Hispanics/Latinos in Alzheimer's research
Official title: A Precision Engagement Approach with Hispanics/Latinos for Alzheimer’s Disease Research: ECHAR-PE
Funded at University of Houston · NIH-11404047 · Data updated 2026-11-12
A broad effort to engage Hispanics/Latinos in dementia research so they can help shape better, culturally appropriate Alzheimer’s care and measurements.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 16, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $930,385 |
| NIH project number | 5UH3AG083264-04 |
| Project ID | NIH-11404047 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21 years or older who identify as Hispanic/Latino and are at risk for or affected by AD/ADRD.
✕Less likely to help
Individuals not interested in research participation or without access barriers may see limited direct benefit.
What this research studies
This project aims to recruit and engage a diverse Hispanic/Latino population for Alzheimer’s disease and related dementias research. It emphasizes culturally and linguistically tailored strategies to build trust, reduce barriers, and create accessible research resources. The goal is to improve representation, create useful data resources, and support precision medicine efforts for AD/ADRD in this community.
Why it matters
Potential benefit: If successful, this work could lead to more accurate understanding and better, more relevant care for Hispanics/Latinos affected by dementia.
How similar studies have gone: Prior efforts show that culturally tailored engagement improves participation and data quality in minority populations, though representation remains limited.
Where this research is happening
-
University of Houston
Houston, United States Active
Researchers
- Principal investigator: Medina, Luis D — University of Houston
- Study coordinator: Medina, Luis D
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.